The past century has seen vast improvements in population health, much of which can be attributed not only to significant scientific discoveries, but to efforts to translate those discoveries into practice more readily. However, with many chronic diseases remaining, new epidemics being introduced, and a changing healthcare landscape characterized by the integration of mental and behavioral health care into primary care settings, it is increasingly imperative that the healthcare field more rapidly integrate high-quality research evidence (e.g., effective clinical interventions and practice guidelines) into clinical practice.
Evidence-based decision making (EBDM) is a multi-component approach to inform clinical practice decision making in an effort to maximize improvements to population health. EBDM theorizes that clinical decisions are best informed when they are based on 1) a rich understanding of population characteristics, needs, values, and preferences; 2) practitioner expertise and other existing resources; and 3) the best available research evidence while 4) accounting for the current environmental and organizational context.
Presenter: Alex Ramsey, PhD, is a NIMH Postdoctoral Research Scholar at Washington University’s Brown School of Social Work. Dr. Ramsey received his PhD in Applied Psychology from Southern Illinois University in 2012, with an emphasis in behavioral health interventions and program evaluation.
The University of Missouri-Saint Louis, Missouri Institute of Mental Health will be responsible for this program and maintain a record of your continuing education credits earned. The Missouri Institute of Mental Health will award 1 clock hour or 1.2 contact hours (.1 CEUs) for this activity.
This module will talk about early mental health care centers in the state of Missouri including State Hospital Number One in Fulton, the St. Louis County Insane Asylum, and the Saint Louis Hospital for Social Evils. The history of these hospitals, the treatments offered patients, and the management of people with mental illness as affected by social and medical movements form the core of this presentation.
Huntington’s Disease (HD) is a rare (incidence 1:10,000), fatal, inherited neurodegenerative/neuropsychiatric disorder for which there is no known treatment or cure. It is characterized by abnormalities in movement, cognition, and psychiatric disturbances. In the absence of a cure, competent symptomatic treatment and psychosocial support is vital. HD is a family disease, both because of the autosomal dominant inheritance, but also because of the impact of the disease on the family system. Understanding of HD by professionals will aid in providing the best treatment available to optimize care and support for these families.
Consumers with mental illness are at an increased risk of developing Diabetes. In this training, Dr. Casey Williams will discuss ways to screen for Diabetes, potential complications of the disease, and special considerations for treating clients with Diabetes.